BIO PROJECTS - Company finances
|
EUR
|
2021
From: 2021-03-31
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 233,557 | 89,376 | 250,223 | 364,898 | 381,563 |
| Profit before tax | - | - | - | 39,676 | 14,746 |
| Net profit | 150,553 | -30,890 | 53,789 | 32,046 | 10,895 |
| Equity | 152,881 | 36,696 | 90,485 | 122,532 | 133,427 |
| Liabilities | 10,793 | 10,976 | 68,560 | 124,024 | 121,282 |
| Non-current assets | 1,157 | 1,630 | 8,465 | 23,415 | 17,186 |
| Current assets | 162,214 | 45,739 | 149,459 | 220,511 | 221,021 |
| Total assets | 163,371 | 47,369 | 157,924 | 243,926 | 238,207 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 65,122 | 84,523 | 104,548 |
| Social insurance contributions | - | - | 31,841 | 37,049 | 38,997 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | -61.7% | +180.0% | +45.8% | +4.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 92.2% | -65.2% | 34.1% | 13.1% | 4.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.5% | -84.2% | 59.4% | 26.2% | 8.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 64.5% | -34.6% | 21.5% | 8.8% | 2.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 10.9% | 3.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.3 | 0.8 | 1.0 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 140,131 | 32,500 | 57,744 | 72,980 | 76,313 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIO PROJECTS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-06-18 | 2024-06-30 | 0.10 |
| 2024-05-16 | 2024-06-02 | 0.10 |
| 2024-04-23 | 2024-04-29 | 0.10 |
| 2024-01-16 | 2024-01-18 | 81.07 |
| 2022-07-18 | 2022-08-04 | 0.30 |
| 2022-06-16 | 2022-07-04 | 0.30 |
| 2022-05-17 | 2022-06-02 | 0.30 |
| 2022-04-19 | 2022-05-02 | 0.30 |
| 2021-11-16 | 2021-11-18 | 0.54 |
BIO PROJECTS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-14 | 2026-01-14 | 0.43 |
| 2026-01-13 | 2026-01-13 | 97.93 |
| 2026-01-11 | 2026-01-12 | 97.84 |
| 2026-01-08 | 2026-01-10 | 97.48 |
| 2026-01-01 | 2026-01-07 | 0.43 |
| 2025-02-20 | 2025-02-24 | 0.65 |
| 2025-02-16 | 2025-02-17 | 0.65 |
| 2025-02-15 | 2025-02-15 | 0.32 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIO PROJECTS, UAB (code 305727451) is a Private Limited Liability Company operating in architectural activities. In 2025, the company generated revenue of EUR 381.6K, up 4.6% year on year and 52.5% over two years. Net profit fell to EUR 10.9K from EUR 32.0K in 2024 and EUR 53.8K in 2023, indicating a clear decline in profitability despite continued revenue growth. The net profit margin narrowed from 21.5% in 2023 to 8.8% in 2024 and 2.9% in 2025. At year-end 2025, total assets stood at EUR 238.2K, supported by equity of EUR 133.4K and liabilities of EUR 121.3K. The equity ratio was 56.0% and debt-to-equity 0.91, showing a balanced capital structure. Asset turnover reached 1.60x, ROE was 8.2% and ROA 4.6%. Revenue per employee was EUR 76.3K, while profit per employee was EUR 2.2K, reflecting modest earnings efficiency in 2025.